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Aim
The aim of this presentation is to review the molecular
mechanisms necessary for the establishment of HIV-1
latency, their relationship with different cellular and
anatomic reservoirs, as well as the current treatment
strategies targeting viral persistence in latent reservoirs,
their main limitations and future perspectives
Methods
For years, the molecular mechanisms leading to HIV-1
reactivation have been characterised in detail but the study
of latency has remained elusive due to the technical limita-
tions that arise when a negative phenomenon, like the
absence of replication, is studied. Development of new tech-
niques for studying HIV-1 latency, the identification of fac-
tors that restrict retroviral infections, the characterisation of
chromatin structure in the setting of viral integration, and
the discovery of new systems regulating gene expression
Results
Resting lymphocytes represent an extremely restrictive
environment for HIV-1 replication. In contrast, immune
activation of CD4
+ T lymphocytes provides an optimal
context for robust HIV-1 replication. Most mechanisms
to maintain HIV-1 latency operate at transcriptional
level such as the chromosome environment at the site
of integration or the availability of viral and host tran-
scription factors. In addition, HIV-1 integration and
expression can be restrained or enhanced by different
host cell factors such as IkBa, COMMD1, APOBEC3G,
LEDGF and Emerin. Finally, both cellular and viral miR-
NAs could be involved in maintaining HIV-1 latency or
in controlling low-ongoing viral replication. Identifica-
tion of new cellular elements restricting the viral cycle
provides a new paradigm on HIV-1 latency.
Discussion
As a lentivirus, HIV-1 is able to infect resting, non-
dividing cells where the viral genome can be perma-
nently integrated into the host cell chromosomes. Latent
HIV-1 reservoirs are established early during primary
infection in lymphocytes and macrophages and consti-
tute a major barrier to eradication even in the presence
of highly active antiretroviral therapy (HAART). HIV-1
latency should no longer be considered a merely passive
event due to the lack of positive factors but as an active
process that is maintained by cellular elements that reg-
ulate the gene expression program in the infected cell.
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